Baldwin Brothers LLC MA Trims Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Baldwin Brothers LLC MA reduced its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,130 shares of the biopharmaceutical company’s stock after selling 2,151 shares during the period. Baldwin Brothers LLC […]

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Pomalyst Imnovid ,Bristol Myers Squibb ,Christophers Boerner ,Theodorer Samuels ,Bristol Myers Squibb Company Profile ,Exchange Commission ,Bristol Myers Squibb Company ,Baldwin Brothers ,Sevenbridge Financial Group ,Cantor Fitzgerald ,Wealth Architects ,Osterweis Capital Management Inc ,Barclays ,Free Report ,Bridge Financial Group ,Asset Management ,Osterweis Capital Management ,Capital Management ,Capital Markets ,Myers Squibb ,Get Free Report ,Director Theodore ,Myers Squibb Company ,Bristol Myers Squibb Daily ,Nyse Bmy ,Bmy ,Medical ,11012210 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,